Andere talen Hikma Pharmaceuticals PLC

Aandelen

HIK

GB00B0LCW083

Beurs gesloten - London S.E. Andere beurzen 17:35:03 18-04-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
1.789 ^GBX	+0,85%		-1,54%	0,00%

15/04	Hikma Pharmaceuticals PLC kondigt directiewisselingen aan	CI
04/03	Nieuw-Zeelandse aandelen sluiten maandag vlak; voorzitter Fletcher Building stapt op	MT

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Hikma appoints Dr. Hafrun Fridriksdottir as President of Generics business	16/04
Hikma Pharmaceuticals PLC Announces Executive Changes	15/04
FTSE 100 Closes Up 0.12% Ahead of U.K. Jobs Data	11/03
The FTSE 100 Closed Up 0.4% as U.K. Announces Spring Budget Tax Cuts	06/03
Rakuten Medical, Inc. announced that it has received $45 million in funding from Dai-ichi Life Holdings, Inc., Mizuho Bank, Ltd., Hikma Pharmaceuticals PLC, Rakuten Ventures, SBI Holdings, Inc., Investment Arm and another investor	06/03
New Zealand Shares Close Flat on Monday; Fletcher Building Chair Steps Down	04/03
AFT Pharmaceuticals to Expand Global Footprint with Signing of Supply, Production Deals	04/03
AFT Pharmaceuticals Limited Extends License for Maxigesic/Combogesic IV with Hikma Pharmaceuticals	03/03
Barclays cuts Direct Line to equal weight	29/02
Stocks called up following slew of FTSE 100 earnings	29/02
Hyloris Pharmaceuticals: le Maxigesic IV commercialisé aux Etats-unis	28/02
Hyloris Partner Hikma Launches Pain Medication in US, Obtains Approval in Canada	28/02
Merck's Bridion faces generic threat from drugmaker Hikma	26/02
Barclays raises Breedon but cuts Domino's Pizza	23/02
FTSE 100 Closes Up After Nvidia Results Lead to Global Rally	22/02
HIKMA PHARMACEUTICALS : Strong Generics-led finish to 2023	22/02
Berenberg raises Moneysupermarket.com to 'buy'	22/02
Hikma boosts dividend after year of "significant progress"	22/02
Drugmaker Hikma expects profit to be slightly lower in 2024	22/02
Hikma Pharmaceuticals Reports Improved FY23 Profit, Revenue	22/02

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Filters

Headlines

HIKMA PHARMACEUTICALS : Sterke generieke geneesmiddelen tot 2023

22 februari 2024 om 15:22 uur

Hikma Pharmaceuticals PLC: generiek farmakampioen uit het Midden-Oosten

23 mei 2023 om 20:58 uur